Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

99
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Tolerability of Ketogenic Interventions in Amyotrophic Lateral Sclerosis-A Dose-Finding Case Series.

Nutrients·2026
Same author

Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry.

Leukemia·2026
Same author

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.

Neurology·2026
Same author

Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Annals of neurology·2025
Same author

Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.

European journal of neurology·2025
Same author

Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models.

Science translational medicine·2025

Related Experiment Video

Updated: May 17, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.6K

Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?

Johannes Dorst1,2, Jens Dreyhaupt3, Deborah Wernecke3

  • 1Department of Neurology, University of Ulm, Ulm, Germany.

European Journal of Neurology
|April 4, 2025
PubMed
Summary

Hospital-based amyotrophic lateral sclerosis (ALS) studies show selection bias. Patients at specialized centers are younger, male-dominant, and have slower progression, impacting generalizability of findings.

Keywords:
amyotrophic lateral sclerosishospital‐based datapopulation‐based dataprognosisselection bias

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.5K

Related Experiment Videos

Last Updated: May 17, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.5K

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • Amyotrophic lateral sclerosis (ALS) research often yields inconsistent findings due to potential selection bias in hospital-based data.
  • Characterizing this bias is crucial for accurate interpretation of ALS studies.

Purpose of the Study:

  • To investigate and quantify selection bias by comparing a hospital-based ALS center cohort with a population-based ALS registry.
  • To identify demographic and clinical differences that may arise from patient selection at specialized treatment centers.

Main Methods:

  • Comparison of patient data from Ulm University's ALS center (UC) with the Swabia (SR) population-based ALS registry.
  • Analysis of demographic factors, diagnostic delay, disease classification, familial status, progression rate, and treatment modalities.

Main Results:

  • UC patients were younger, had a higher proportion of males, and experienced longer diagnostic delays compared to SR.
  • UC patients showed a higher prevalence of definite El Escorial criteria, familial ALS, slower disease progression, and increased use of gastrostomy and ventilation.
  • Significant differences in patient characteristics and disease trajectory were observed between the hospital-based and population-based cohorts.

Conclusions:

  • Observed disparities suggest a notable selection bias in hospital-based ALS data.
  • Factors such as willingness to travel, participation in clinical trials, and preference for life-prolonging treatments contribute to this bias.
  • Findings underscore the need to consider selection bias when interpreting and generalizing results from hospital-based ALS studies.